Mining the FAERS database reveals new safety signals for 120 mg denosumab in oncology practice
Clinicians should maintain vigilance for both established toxicities and these 32 emerging signals to ensure the safety of patients receiving 120 mg of denosumab for oncological purposes.
Authors
- Dongxiao Wang (ORCID: https://orcid.org/0000-0001-5358-196X)
- S. Lu
- Canhua Liang
- Jialing Liang
- Qianxi Chen
- Caiming Xiong
- Guangyi Meng
- Yang Li
Institutions
- Guangxi Medical University (CN)
- Yulin Normal University (CN)
- Yulin Orthopedics Hospital of Chinese and Western Medicine (CN)
Publication Details
- Journal
- PLoS ONE
- Published
- 2026-02-02
- DOI
- https://doi.org/10.1371/journal.pone.0342188
- Citations
- 1
- Primary Topic
- Bone health and treatments
- Type
- article
- Field-Weighted Citation Impact
- 24.20